Literature DB >> 30706177

Comparative effectiveness of low-level laser therapy for adult androgenic alopecia: a system review and meta-analysis of randomized controlled trials.

Kao-Hui Liu1,2, Donald Liu1, Yu-Tsung Chen1, Szu-Ying Chin3.   

Abstract

The purpose of this review is to explore the effectiveness of low-level laser therapy (LLLT) in the treatment of adult androgenic alopecia (AGA). A systematic search of studies on LLLT for AGA was conducted mainly in Pubmed, Embase, and Cochrane Systematic Reviews. The standardized mean difference (SMD) in the changes of hair density treated by LLLT versus sham devices was analyzed. The meta-analysis included 8 studies comprising a total of 11 double-blinded randomized controlled trials. The quantitative analysis showed a significant increase in hair density for those treated by LLLT versus sham group (SMD 1.316, 95% confidence interval, CI 0.993 to 1.639). The subgroup analysis demonstrated that LLLT increases hair growth in both genders, in both comb- and helmet-type devices, and in short- and long-term treatment course. The subgroup analysis also showed a more significant increase of hair growth for the LLLT versus sham in the low-frequency treatment group (SMD 1.555, 95% CI 1.132 to 1.978) than in the high-frequency group (SMD 0.949, 95% CI 0.644 to 1.253). The review was limited by the heterogeneity of included trials. LLLT significantly increased hair density in AGA. The meta-analysis suggests that low treatment frequency by LLLT have a better hair growth effect than high treatment frequency. LLLT represents a potentially effective treatment for AGA in both male and female. The types of LLLT devices and LLLT treatment course duration did not affect the effectiveness in hair growth.

Entities:  

Keywords:  Adult androgenic alopecia; Hair growth; Low-level laser therapy; Meta-analysis

Mesh:

Year:  2019        PMID: 30706177     DOI: 10.1007/s10103-019-02723-6

Source DB:  PubMed          Journal:  Lasers Med Sci        ISSN: 0268-8921            Impact factor:   3.161


  25 in total

1.  HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial.

Authors:  Matt Leavitt; Glenn Charles; Eugene Heyman; David Michaels
Journal:  Clin Drug Investig       Date:  2009       Impact factor: 2.859

Review 2.  The psychosocial consequences of androgenetic alopecia: a review of the research literature.

Authors:  T F Cash
Journal:  Br J Dermatol       Date:  1999-09       Impact factor: 9.302

Review 3.  A review of medical and surgical treatment options for androgenetic alopecia.

Authors:  Daniel E Rousso; Sang W Kim
Journal:  JAMA Facial Plast Surg       Date:  2014 Nov-Dec       Impact factor: 4.611

4.  The growth of human scalp hair mediated by visible red light laser and LED sources in males.

Authors:  Raymond J Lanzafame; Raymond R Blanche; Adam B Bodian; Richard P Chiacchierini; Adolfo Fernandez-Obregon; Eric R Kazmirek
Journal:  Lasers Surg Med       Date:  2013-10       Impact factor: 4.025

Review 5.  Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review.

Authors:  José Manuel Mella; María Clara Perret; Matías Manzotti; Hugo Norberto Catalano; Gordon Guyatt
Journal:  Arch Dermatol       Date:  2010-10

Review 6.  Utilizing electromagnetic radiation for hair growth: a critical review of phototrichogenesis.

Authors:  Sunil Kalia; Harvey Lui
Journal:  Dermatol Clin       Date:  2012-10-11       Impact factor: 3.478

7.  Low-level light therapy for androgenetic alopecia: a 24-week, randomized, double-blind, sham device-controlled multicenter trial.

Authors:  Hyojin Kim; Jee Woong Choi; Jun Young Kim; Jung Won Shin; Seok-Jong Lee; Chang-Hun Huh
Journal:  Dermatol Surg       Date:  2013-04-03       Impact factor: 3.398

Review 8.  Low-level laser therapy as a treatment for androgenetic alopecia.

Authors:  Ladan Afifi; Eric L Maranda; Mina Zarei; Gina M Delcanto; Leyre Falto-Aizpurua; Wouter P Kluijfhout; Joaquin J Jimenez
Journal:  Lasers Surg Med       Date:  2016-04-25       Impact factor: 4.025

9.  The growth of human scalp hair in females using visible red light laser and LED sources.

Authors:  Raymond J Lanzafame; Raymond R Blanche; Richard P Chiacchierini; Eric R Kazmirek; Jeffrey A Sklar
Journal:  Lasers Surg Med       Date:  2014-08-13       Impact factor: 4.025

10.  Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study.

Authors:  Joaquin J Jimenez; Tongyu C Wikramanayake; Wilma Bergfeld; Maria Hordinsky; Janet G Hickman; Michael R Hamblin; Lawrence A Schachner
Journal:  Am J Clin Dermatol       Date:  2014-04       Impact factor: 7.403

View more
  5 in total

1.  Photobiomodulation for the management of alopecia: mechanisms of action, patient selection and perspectives.

Authors:  Michael R Hamblin
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-09-06

2.  Hair Growth Promoting Effects of 650 nm Red Light Stimulation on Human Hair Follicles and Study of Its Mechanisms via RNA Sequencing Transcriptome Analysis.

Authors:  Kai Yang; Yulong Tang; Yanyun Ma; Qingmei Liu; Yan Huang; Yuting Zhang; Xiangguang Shi; Li Zhang; Yue Zhang; Ji'an Wang; Yifei Zhu; Wei Liu; Yimei Tan; Jinran Lin; Wenyu Wu
Journal:  Ann Dermatol       Date:  2021-11-04       Impact factor: 1.444

Review 3.  Advances in hair growth.

Authors:  Dmitri Wall; Nekma Meah; Nicole Fagan; Katherine York; Rodney Sinclair
Journal:  Fac Rev       Date:  2022-01-12

4.  Non-ablative Er:YAG laser is an effective tool in the treatment arsenal of androgenetic alopecia.

Authors:  Doris Day; Madison McCarthy; Iva Talaber
Journal:  J Cosmet Dermatol       Date:  2021-08-26       Impact factor: 2.189

5.  Low-level light therapy using a helmet-type device for the treatment of androgenetic alopecia: A 16-week, multicenter, randomized, double-blind, sham device-controlled trial.

Authors:  Jung Soo Yoon; Won Young Ku; Jang Hyun Lee; Hee Chang Ahn
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.